Mannose-Binding Lectin (MBL) substitution: Recovery of opsonic function in vivo lags behind MBL serum levels

Medicijnen en Levenswetenschappen

• Mannose-Binding Lectin 100%
• Recovery of Function 78%
• Serum 32%
• Mannose-Binding Protein-Associated Serine Proteases 19%
• Complement Activation 13%
• Mannose-Binding Protein Deficiency 6%
• Complement C4 5%
• Alternative Complement Pathway 5%
• Pediatrics 5%
• Complement C3 4%
• Zymosan 4%
• Serine Proteases 4%
• Immunocompromised Host 4%
• Neutropenia 4%
• In Vitro Techniques 3%
• Neutrophils 3%
• Pharmacokinetics 3%
• Drug Therapy 2%
• Safety 2%
• Infections 1%